Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Yumi Miyashita"'
Autor:
Takuya Awata, Hisakuni Yamashita, Susumu Kurihara, Tomoko Morita-Ohkubo, Yumi Miyashita, Shigehiro Katayama, Keisuke Mori, Shin Yoneya, Masakazu Kohda, Yasushi Okazaki, Taro Maruyama, Akira Shimada, Kazuki Yasuda, Nao Nishida, Katsushi Tokunaga, Asako Koike
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0126789 (2015)
Externí odkaz:
https://doaj.org/article/16f962b1392848f8a6f203cc7173b26a
Autor:
Takuya Awata, Hisakuni Yamashita, Susumu Kurihara, Tomoko Morita-Ohkubo, Yumi Miyashita, Shigehiro Katayama, Keisuke Mori, Shin Yoneya, Masakazu Kohda, Yasushi Okazaki, Taro Maruyama, Akira Shimada, Kazuki Yasuda, Nao Nishida, Katsushi Tokunaga, Asako Koike
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111715 (2014)
Elucidation of the genetic susceptibility factors for diabetic retinopathy (DR) is important to gain insight into the pathogenesis of DR, and may help to define genetic risk factors for this condition. In the present study, we conducted a three-stage
Externí odkaz:
https://doaj.org/article/2c8258329fa24c00abd347096f4fcf40
Autor:
Naotoshi Sugimoto, Yumi Miyashita, Takaki Yoshikawa, Masakazu Takagi, Masato Nakamura, Shigeyuki Tamura, Hiroko Hasegawa, Kenta Murotani, Akira Tsuburaya, Junichi Sakamoto, Kazuhiro Nishikawa, Tadashi Shigematsu, Kazumasa Fujitani, Hitoshi Inagaki, Tohru Ishiguro, Satoshi Morita, Shinya Tokunaga, Yusuke Akamaru, Toshimasa Tsujinaka
Publikováno v:
European Journal of Cancer. 132:159-167
Background Second-line chemotherapy (SLC) improves survival in advanced gastric cancer (AGC). Patients receiving SLC are categorized into two disease status groups: tumour progression after first-line chemotherapy and early recurrence after adjuvant
Autor:
Junichi Sakamoto, Akira Tsuburaya, Lieven Desmet, Kazuhiro Yoshida, Marc Buyse, Satoshi Morita, Tomasz Burzykowski, Koji Oba, Laura Trotta, Yuusuke Kabeya, Paurush Praveen, David Venet, Erik Doffagne, Yumi Miyashita
Publikováno v:
Clinical Trials. 16:512-522
Background/Aims A risk-based approach to clinical research may include a central statistical assessment of data quality. We investigated the operating characteristics of unsupervised statistical monitoring aimed at detecting atypical data in multicen
Autor:
Jia Guan, Shiro Tanaka, Takashi Oshima, Takaki Yoshikawa, Kazuaki Tanabe, Akira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi, Yumi Miyashita, Shigefumi Yoshino, Junichi Sakamoto
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 24(6)
Adjuvant therapy for gastric cancer is a standard among the world with no regimen selection criteria. Also, prognostic factors except for tumor staging have not been established. We aimed to identify prognostic and predictive markers for gastric canc
Autor:
Takako Shirasawa, Yumi Miyashita, Hirotaka Ochiai, Toru Matsudaira, Naoko Tajima, Hironari Sano, Rimei Nishimura, Akatsuki Kokaze
Background It is not clear whether resistin, adiponectin and leptin are as closely associated with cardiovascular disease risk in childhood as in adulthood. Methods A survey was performed on elementary school 4 th graders aged 9 to 10 years in Ina-ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::578e0795273621af11271d8f56702d60
https://doi.org/10.21203/rs.2.22485/v1
https://doi.org/10.21203/rs.2.22485/v1
Autor:
Akihito Tsuji, Hiroshi Yabusaki, Kazumasa Fujitani, Toru Aoyama, Satoshi Morita, Masazumi Takahashi, Shigefumi Yoshino, Tsutomu Namikawa, Kazuaki Tanabe, Yasushi Rino, Kazuhiro Nishikawa, Junji Kawada, Yoshinori Hirashima, Takaki Yoshikawa, Yutaka Kimura, Akira Tsuburaya, Junichi Sakamoto, Koichi Taira, Yumi Miyashita, Kensei Yamaguchi, Yasuhiro Kodera, Naoki Hirabayashi
Publikováno v:
Gastric Cancer. 21:811-818
In Japan, standard regimens for advanced gastric cancer (AGC) include S-1 chemotherapy. The standard treatment for early relapse after adjuvant chemotherapy with fluoropyrimidine alone is platinum-based chemotherapy, while the standard treatment for
Autor:
Yumi Miyashita, Shigefumi Yoshino, Junichi Sakamoto, Akira Tsuburaya, Takaki Yoshikawa, Kazuhiro Yoshida, Takashi Oshima, Jia Guan, Michiya Kobayashi, Kazuaki Tanabe, Shiro Tanaka
Publikováno v:
Annals of Cancer Research and Therapy. 26:43-45
Autor:
Haruhiko Cho, Toru Aoyama, Akira Tsuburaya, Tsutomu Hayashi, Satoshi Morita, Yutaka Kimura, Takanori Matsui, Yumi Miyashita, Takaki Yoshikawa, Kazuhiro Nishikawa, Junya Fujita, Yuichi Ito, Kazumasa Fujitani, Kazuaki Tanabe, Junichi Sakamoto
Publikováno v:
European Journal of Cancer. 62:103-111
Background The prognosis for stage III gastric cancer is unsatisfactory by D2 gastrectomy and S-1 adjuvant chemotherapy. Both S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) are promising regimens as neoadjuvant chemotherapy; however, the
Autor:
Yasuhiro Kodera, Naoto Takahashi, Yumi Miyashita, Nobuhiro Takiguchi, Osamu Takayama, Daisuke Kobayashi, Takaki Yoshikawa, Motohiro Imano, Junichi Sakamoto, Katsufumi Miyamoto, Kazumasa Fujitani, Satoshi Morita, Yuichi Ito
Publikováno v:
Gastric Cancer. 20:190-199
Peritoneal carcinomatosis is common after curative resection of gastric cancer. Intraperitoneal administration of paclitaxel (PTX) is known to control ovarian peritoneal metastases.Patients with either linitis plastica or T4 cancer with high risk of